Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Salmeterol/fluticasone proprionate - Teva Pharmaceutical Industries

Next Previous
X
Search
Drug Profile

Salmeterol/fluticasone proprionate - Teva Pharmaceutical Industries

Alternative Names: Aerivio Spiromax®; AirDuo Digihaler; AirDuo RespiClick; BroPair Spiromax; Fluticasone propionate/salmeterol - Teva; Fluticasone propionate/salmeterol MDI; Fluticasone propionate/salmeterol MDPI; Fluticasone/salmeterol Spiromax® inhalation powder; FS Spiromax; Salmeterol xinafoate/fluticasone propionate - Teva; Salmeterol/fluticasone propionate RespiClick®; Salmeterol/fluticasone propionate Spiromax®; Seffalair Spiromax

Latest Information Update: 09 Apr 2021

Price :

$50 *

Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Teva Pharmaceutical Industries
  • Class Androstadienes; Antiallergics; Antiasthmatics; Bronchodilators; Ethanolamines; Glucocorticoids; Phenethylamines; Small molecules
  • Mechanism of Action Arachidonic acid inhibitors; Beta 2 adrenergic receptor agonists; Glucocorticoid receptor agonists; Lipocortin synthesis agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Asthma
  • Registered Chronic obstructive pulmonary disease

Most Recent Events

  • 09 Apr 2021 Teva Pharmaceutical plans initial launch of salmeterol xinafoate / fluticasone propionate in Asthma (In adolescents, In adults) in Portugal, Switzerland, Spain and the UK
  • 08 Apr 2021 Registered for Asthma (In adolescents, In adults) in European Union, Liechtenstein, Iceland and Norway (Inhalation)
  • 29 Jan 2021 Preregistration for Asthma (In adolescents, In adults) in European Union (Inhalation) before January 2021

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top